No Data
Xinwei Medical -B (06609.HK) will hold a board of directors meeting on August 30 to approve interim performance.
On August 20th, Gelonhui announced that Heartway Medical-B (06609.HK) will hold a board of directors meeting on August 30th, 2024 to approve the mid-term performance of the company and its subsidiary companies until June 30th, 2024, and consider the distribution of mid-term dividends (if any).
China's Medical Device Market Value Hits $179B, 90th CMEF in Shenzhen to Feature a Plethora of Technological Products
Sinolink Securities: The pharmaceutical sector is expected to see an improvement in market conditions in the third quarter, and overall growth expectations for the second half of the year are optimistic.
Sinolink Securities released a research report stating that considering the improvement in the medical insurance settlement cycle, the expectation of policy improvement, and the recovery performance of the industry, as well as the fact that institutional medicine hold positions are at a low level, the medical sector will usher in an improved market situation in Q3.
Hong Kong stock concept tracking | The Ministry of Industry and Information Technology has issued a document! Regarding the brain-computer interface, institutions: Focus on the possibility of implementing scenarios (with concept stocks attached)
Tianfeng Securities believes that the brain-computer interface market has broad potential, frequent encouragement policies, and diverse application scenarios.
Hong Kong Stock Concept Tracking | New Advances in Brain-Computer Interface Technology! Neuralink begins recruiting a second patient (with concept stock)
Musk announced that after 100 days of successful surgery for the first patient involved in the brain-computer device implantation experiment at the beginning of the year, Neuralink (Neuralink) has officially begun recruiting a second patient to receive a brain-computer implantation.
Zhongtai Securities: Steady performance under the influence of policies and fundamentals, grasping investment opportunities driven by medical device innovation+ inflection points
The medical device industry continues to grow rapidly. It is optimistic about importation substitution and global development driven by innovation. Volume procurement policies will continue to be implemented, medical anti-corruption is expected to ease, and sector valuations are expected to gradually recover.
No Data
